Literature DB >> 34045188

NEIL3 Prevents Senescence in Hepatocellular Carcinoma by Repairing Oxidative Lesions at Telomeres during Mitosis.

Helge Gad1,2, Zhicong Zhao3, Zhenjun Zhao1,3, Carlos Benitez-Buelga1, Kumar Sanjiv1, Hua Xiangwei4, He Kang3, Mingxuan Feng3, Ulrika Warpman Berglund1, Qiang Xia5, Thomas Helleday6,2.   

Abstract

Patients with hepatocellular carcinoma (HCC) suffer from few treatment options and poor survival rates. Here we report that endonuclease VIII-like protein 3 (NEIL3) is overexpressed in HCC and correlates with poor survival. All six HCC cell lines investigated were dependent on NEIL3 catalytic activity for survival and prevention of senescence, while NEIL3 was dispensable for nontransformed cells. NEIL3-depleted HCC cell lines accumulated oxidative DNA lesions specifically at telomeres, resulting in telomere dysfunctional foci and 53BP1 foci formation. Following oxidative DNA damage during mitosis, NEIL3 relocated to telomeres and recruited apurinic endonuclease 1 (APE1), indicating activation of base excision repair. META-FISH revealed that NEIL3, but not NEIL1 or NEIL2, is required to initiate APE1 and polymerase beta (POLB)-dependent base excision repair at oxidized telomeres. Repeated exposure of NEIL3-depleted cells to oxidizing damage induced chromatin bridges and damaged telomeres. These results demonstrate a novel function for NEIL3 in repair of oxidative DNA damage at telomeres in mitosis, which is important to prevent senescence of HCC cells. Furthermore, these data suggest that NEIL3 could be a target for therapeutic intervention for HCC. SIGNIFICANCE: This study describes compartmentalization of base excision repair during mitosis that is dependent on NEIL3, APE1, and POLB to repair oxidative damage accumulating at telomeres in hepatocellular carcinoma. ©2021 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34045188     DOI: 10.1158/0008-5472.CAN-20-1028

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

1.  Comprehensive Molecular Analyses of a Macrophage-Related Gene Signature With Regard to Prognosis, Immune Features, and Biomarkers for Immunotherapy in Hepatocellular Carcinoma Based on WGCNA and the LASSO Algorithm.

Authors:  Tao Wang; Liqun Dai; Shu Shen; Yi Yang; Ming Yang; Xianwei Yang; Yiwen Qiu; Wentao Wang
Journal:  Front Immunol       Date:  2022-05-27       Impact factor: 8.786

2.  NEIL3 Mediates Lung Cancer Progression and Modulates PI3K/AKT/mTOR Signaling: A Potential Therapeutic Target.

Authors:  Hongbo Huang; Qingwang Hua
Journal:  Int J Genomics       Date:  2022-04-30       Impact factor: 2.758

3.  NEIL3-deficient bone marrow displays decreased hematopoietic capacity and reduced telomere length.

Authors:  Tom Rune Karlsen; Maria B Olsen; Xiang Y Kong; Kuan Yang; Ana Quiles-Jiménez; Penelope Kroustallaki; Sverre Holm; Glenn Terje Lines; Pål Aukrust; Tonje Skarpengland; Magnar Bjørås; Tuva B Dahl; Hilde Nilsen; Ida Gregersen; Bente Halvorsen
Journal:  Biochem Biophys Rep       Date:  2022-01-18

4.  Development and Validation of a Pyroptosis-Related Signature for Predicting Prognosis in Hepatocellular Carcinoma.

Authors:  Jianfeng Ding; Xiaobo He; Wei Luo; Weiguo Zhou; Rui Chen; Guodong Cao; Bo Chen; Maoming Xiong
Journal:  Front Genet       Date:  2022-01-24       Impact factor: 4.599

5.  Induction of senescence upon loss of the Ash2l core subunit of H3K4 methyltransferase complexes.

Authors:  Agnieszka Bochyńska; Alexander T Stenzel; Roksaneh Sayadi Boroujeni; Chao-Chung Kuo; Mirna Barsoum; Weili Liang; Philip Bussmann; Ivan G Costa; Juliane Lüscher-Firzlaff; Bernhard Lüscher
Journal:  Nucleic Acids Res       Date:  2022-08-12       Impact factor: 19.160

6.  Identification of multi-omics biomarkers and construction of the novel prognostic model for hepatocellular carcinoma.

Authors:  Xiao Liu; Chiying Xiao; Kunyan Yue; Min Chen; Hang Zhou; Xiaokai Yan
Journal:  Sci Rep       Date:  2022-07-15       Impact factor: 4.996

7.  Characterization of chromatin regulators identified prognosis and heterogeneity in hepatocellular carcinoma.

Authors:  Yin-Wei Dai; Han-Bin Chen; Ya-Ting Pan; Lin-Xi Lv; Wei-Ming Wang; Xiao-Hu Chen; Xiang Zhou
Journal:  Front Oncol       Date:  2022-09-09       Impact factor: 5.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.